Evidence map›Paper›PMID 33766945›Full record

ArticleThe European respiratory journal2021

Circulating fibrocytes are not disease-specific prognosticators in idiopathic pulmonary fibrosis.

Iain D Stewart, Henry Nanji, Grazziela Figueredo, William A Fahy, Toby M Maher, Antje J Ask, Shyam Maharaj, Kjetil Ask, Martin Kolb, Gisli R Jenkins

Open access · hybridAbstract readLetter
In one paragraph

Article in The European respiratory journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Circulating Fibrocytes: Cellular Mediators of Tissue Fibrosis.International journal of molecular sciences · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Mechanisms and Therapeutic Potential of Myofibroblast Transformation in Pulmonary Fibrosis.Journal of respiratory biology and translational medicine · 2025
    Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Iain D StewartDivision of Respiratory Medicine, NIHR Biomedical Research Centre, University of Nottingham, Nottingham, UK iain.stewart@imperial.ac.uk.ORCID 0000-0002-1340-2688
Henry NanjiAdvanced Data Analysis Centre, School of Computer Science, University of Nottingham, Nottingham, UK.
Grazziela FigueredoAdvanced Data Analysis Centre, School of Computer Science, University of Nottingham, Nottingham, UK.
William A FahyDiscovery Medicine, GlaxoSmithKline R&D, GlaxoSmithKline Medicines Research Centre, Stevenage, UK.
Toby M MaherFaculty of Medicine, National Heart and Lung Institute, Imperial College London, London, UK.
Antje J AskDivision of Respirology, Dept of Medicine, McMaster University, Hamilton, ON, Canada.
Shyam MaharajDivision of Respirology, Dept of Medicine, McMaster University, Hamilton, ON, Canada.
Kjetil AskDivision of Respirology, Dept of Medicine, McMaster University, Hamilton, ON, Canada.ORCID 0000-0002-0202-735X
Martin KolbDivision of Respirology, Dept of Medicine, McMaster University, Hamilton, ON, Canada.ORCID 0000-0003-3837-1467
Gisli R JenkinsDivision of Respiratory Medicine, NIHR Biomedical Research Centre, University of Nottingham, Nottingham, UK.
McMaster University · CAUniversity of Nottingham · GBGlaxoSmithKline (United Kingdom) · GBUniversity of Southern California · US

Funding

Department of HealthMedical Research Council
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Idiopathic Pulmonary FibrosisFibroblastsFibrosisHumans

Identifiers

PMID33766945
PMCPMC8295504
OpenAlexW3139062550

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.